Primary study · included by 1 review

Oncologic outcome of parotid mucoepidermoid carcinoma in pediatric patients.

Fang Q, 2019 · Fang Qigen, Liu Fei, Seng Dongjie · Cancer management and research · 2019

Included by

Outcome this study informsPooled effectEvidenceCertainty
10-year disease-specific survival
Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 10 years
Proportion 0.9 [0.8, 0.9]4 studiesGRADE not reported
10-year disease-specific survival
Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 10 years
Proportion 0.9 [0.7, 1.0]5 studies · 1594 participantsGRADE not reported
10-year disease-specific survival
Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 10 years
Proportion 0.9 [0.8, 0.9]4 studiesGRADE not reported
10-year disease-specific survival
Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 10 years
Proportion 0.9 [0.8, 0.9]4 studiesGRADE not reported
10-year disease-specific survival
Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 10 years
Proportion 0.9 [0.8, 0.9]4 studiesGRADE not reported
10-year disease-specific survival
Any treatment (mainly parotidectomy with or without neck dissection and postoperative radiotherapy); single-arm vs None (single-arm pooled proportion) · 10 years
Proportion 0.9 [0.9, 0.9]4 studiesGRADE not reported

1 including review in total.